Filing Flows › GSK (GSK) › Who owns the stock
Who owns GSK (GSK) stock
965 funds reported GSK (GSK) shares in their latest 13F filings, worth $17.8B in all. The largest holder is FMR LLC ($3.4B). Last quarter 420 funds added to their stakes and 393 cut them. Members of Congress and other officials disclosed 1 trade (0 buys, 1 sales).
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| FMR LLC | 64,961,641 | $3.4B | decrease | 2026-06-30 |
| Dodge & COX | 48,197,514 | $2.5B | decrease | 2026-06-30 |
| Fisher Asset Management, LLC | 35,722,792 | $1.9B | increase | 2026-06-30 |
| Primecap Management | 25,182,068 | $1.3B | decrease | 2026-06-30 |
| Wellington Management Group LLP | 11,396,249 | $597M | decrease | 2026-06-30 |
| JTC Employer Solutions Trustee | 8,592,987 | $450M | decrease | 2026-06-30 |
| Morgan Stanley | 7,657,562 | $401M | decrease | 2026-06-30 |
| Royal Bank of Canada | 7,588,928 | $398M | increase | 2026-06-30 |
| Price T Rowe Associates | 6,923,642 | $363M | decrease | 2026-06-30 |
| Acadian Asset Management LLC | 6,660,434 | $349M | decrease | 2026-06-30 |
| Goldman Sachs Group | 6,371,442 | $334M | decrease | 2026-06-30 |
| State Street | 5,959,115 | $315M | decrease | 2026-06-30 |
| Mondrian Investment Partners | 4,965,946 | $239M | increase | 2026-09-30 |
| Bank of Montreal | 4,042,863 | $212M | decrease | 2026-06-30 |
| BlackRock | 3,620,294 | $190M | increase | 2026-06-30 |
Trades by Congress and other officials
| Date | Who | Trade | Amount |
|---|---|---|---|
| 2025-10-31 | Lisa McClain | sale | $1K–$15K |
GSK's latest quarter
GSK, Q3 2026: revenue $8.5B, operating margin 30.3%, net earnings $2.0B. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most GSK stock?
By the latest 13F filings: FMR LLC ($3.4B); Dodge & COX ($2.5B); Fisher Asset Management, LLC ($1.9B); Primecap Management ($1.3B); Wellington Management Group LLP ($597M).
Has Congress traded GSK stock?
Officials disclosed 1 trade on file: 0 buys and 1 sales. The latest: Lisa McClain, sale on 2025-10-31.
What is the short interest in GSK?
14,579,567 shares were sold short at the 2026-10-15 settlement, -1.47% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.